BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24305580)

  • 1. High-risk profile in a region with extremely elevated cardiovascular mortality.
    Laucevičius A; Rinkūnienė E; Skorniakov V; Petrulionienė Z; Kasiulevičius V; Jatužis D; Ryliškytė L; Badarienė J; Klumbienė J; Slapikas R; Kizlaitis R;
    Hellenic J Cardiol; 2013; 54(6):441-7. PubMed ID: 24305580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in major risk factors and mortality from main non-communicable diseases in Lithuania, 1985-2013.
    Tamosiunas A; Klumbiene J; Petkeviciene J; Radisauskas R; Vikhireva O; Luksiene D; Virviciute D
    BMC Public Health; 2016 Aug; 16():717. PubMed ID: 27492379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cardiovascular risk factors in Lithuanian middle-aged subjects participating in the primary prevention program, analysis of the period 2009-2012.
    Laucevičius A; Rinkūnienė E; Skujaitė A; Petrulionienė Ž; Puronaitė R; Dženkevičiūtė V; Kasiulevičius V; Jatužis D; Ryliškytė L; Šlapikas R
    Blood Press; 2015 Feb; 24(1):41-7. PubMed ID: 25268930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cardiovascular risk factor prevalence among Lithuanian middle-aged adults between 2009 and 2018.
    Laucevičius A; Rinkūnienė E; Petrulionienė Ž; Ryliškytė L; Jucevičienė A; Puronaitė R; Badarienė J; Navickas R; Mikolaitytė J; Gargalskaitė U; Dženkevičiūtė V; Kutkienė S; Gimžauskaitė S; Mainelis A; Šlapikas R; Gurevičius R; Jatužis D; Kasiulevičius V
    Atherosclerosis; 2020 Apr; 299():9-14. PubMed ID: 32179208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profile evaluation and severe hypercholesterolaemia screening in the middle-aged population according to nationwide primary prevention programme in Lithuania.
    Kutkiene S; Petrulioniene Z; Laucevicius A; Cerkauskiene R; Staigyte J; Saulyte A; Petrulionyte E; Gargalskaite U; Skiauteryte E; Matuzeviciene G; Kovaite M; Rinkuniene E
    Atherosclerosis; 2018 Oct; 277():267-272. PubMed ID: 30270057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of healthy diet and physical activity on the level of non-HDL cholesterol in obese subjects without cardiovascular disease and diabetes mellitus].
    Móczár C
    Orv Hetil; 2015 Oct; 156(42):1710-4. PubMed ID: 26551311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009-2016 in Lithuania.
    Kutkiene S; Petrulioniene Z; Laucevicius A; Serpytis P; Kasiulevicius V; Staigyte J; Saulyte A; Petrulionyte E; Gargalskaite U; Skiauteryte E; Matuzeviciene G; Kovaite M; Rinkuniene E
    Lipids Health Dis; 2018 Oct; 17(1):233. PubMed ID: 30305084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of high-risk profile in middle-aged subjects with arterial hypertension: a nationwide survey.
    Laucevičius A; Rinkūnienė E; Petrulionienė Z; Puronaitė R; Kasiulevičius V; Jatužis D; Ryliškytė L; Badarienė J; Cypienė A; Navickas R; Kizlaitis R; Gustienė O; Slapikas R
    Blood Press; 2014 Oct; 23(5):281-7. PubMed ID: 24533617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Patients with Coronary Artery Disease in Lithuania: a Comparison with Other Central Eastern European Countries Based on Data From the International CLARIFY Registry.
    Badarienė J; Rinkūnienė E; Kasiulevičius V; Smaliukaitė G; Selskaitė V; Barysienė J; Dženkevičiūtė V
    Adv Ther; 2020 Jun; 37(6):3010-3018. PubMed ID: 32221794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of metabolic syndrome components in patients with acute coronary syndromes].
    Zaliūnas R; Slapikas R; Luksiene D; Slapikiene B; Statkeviciene A; Milvidaite I; Gustiene O
    Medicina (Kaunas); 2008; 44(3):182-8. PubMed ID: 18413984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya.
    Kimando MW; Otieno FCF; Ogola EN; Mutai K
    BMC Endocr Disord; 2017 Dec; 17(1):73. PubMed ID: 29191193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.